Tremblay, Jacques P

9 enregistrements totalisant 3,136,079.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Instituts de recherche en santé du Canada $3,136,079 9 enregistrements

Enregistrements

Tremblay, Jacques P $769,244.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2019-2020
Canada

Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization; Promote relevant collaborations acro...

TREMBLAY, Jacques P $649,181.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada

Correction of the dystrophin gene with Zinc Finger Proteins and TAL effector nuclease.

TREMBLAY, Jacques P $535,740.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada

Can laminin-111 be used to treat Duchenne Muscular Dystrophy alone or in combination with myoblast transplantation?

TREMBLAY, Jacques P $462,858.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada

Phase I/II clinical trial of myoblast transplantation to Duchenne Muscular Dystrophy patients.

Tremblay, Jacques P $199,125.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas. The specif...

TREMBLAY, Jacques P $160,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada

Development of a treatment for Friedreich ataxia based on the administration of TALE proteins targeting the frataxin promoter.

Tremblay, Jacques P $159,931.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2015-2016
Canada

Alzheimer treatment based on the editing of the Amyloid Precursor Protein gene

Tremblay, Jacques P $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada

Correction of the DMD gene with the CRISPR/Cas9 technology: restoring the reading frame and production of a dystrophin protein with an adequate structure.

Tremblay, Jacques P $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2022-2023
Canada

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate: o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspect...